Neurogene Inc.

NASDAQ:NGNE

Biotechnology

Healthcare
$23.14 +2.47%

+$0.76 today

Market cap
$365.67M
Beta
2.04
P/E (TTM)
-7.1
EPS (TTM)
-$4.42
52W Low $14.65High $37.27

Volume 0.25M

Average 0.16M

Balance Sheet

Inspect the capital base behind the business.

Assets

$288.60M

FY 2025 · Annual

-14.0% YoY

Liabilities

$23.72M

FY 2025 · Annual

-6.5% YoY

Equity

$264.89M

FY 2025 · Annual

-14.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents70.54M82.02M148.21M136.59M103.85M
Short-term Investments0048.95M175.82M165.17M
Net Receivables790K0600K648K0
Inventory1.91M0000
Other Current Assets(1.2M)1.62M1.1M981K2.76M
Total Current Assets73.96M84.72M200.35M315.92M271.77M
Property, Plant & Equipment (Net)27.53M24.55M20.95M18.49M15.46M
Goodwill00000
Intangible Assets128K0000
Long-term Investments878K0000
Tax Assets00000
Other Non-current Assets(1.01M)01.27M1.31M1.37M
Total Non-current Assets27.53M24.55M22.23M19.81M16.83M
Total Assets101.49M109.27M222.57M335.73M288.6M
Account Payables5.63M625K2.6M1.34M1.95M
Short-term Debt1.22M003M3.06M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities132K167K6.71M1.43M6.32M
Total Current Liabilities10.86M6.65M22.97M15.16M16.41M
Long-term Debt00006.83M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities177.91M0203K769K479K
Total Non-current Liabilities182.51M3.99M13.58M10.2M7.31M
Total Liabilities193.36M10.64M36.55M25.36M23.72M
Common Stock1K0000
Retained Earnings(95.65M)(150.84M)(187.15M)(262.3M)(352.65M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity(91.88M)98.63M186.02M310.38M264.89M
Total Debt6.43M4.69M16.26M12.43M9.89M
Net Debt(64.11M)(77.33M)(131.96M)(124.16M)(93.95M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$124.2M
Short-term Investments$119.0M
Other Current$3.6M
Total Current Assets$246.7M
PP&E (Net)$15.0M
Other Non-current$1.4M
Total Non-current Assets$16.4M
Total Assets$263.1M

Analysis

Selected assets total $263.1M for Latest. The largest visible component is Cash & Equivalents at $124.2M, about 47.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
SC 13GSC 13G filingOct 7, 2026
SC 13GSC 13G filingOct 6, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

How much cash does NGNE have?

Neurogene Inc. (NGNE) reported $103.84M in cash and equivalents in fiscal 2025.

How much debt does NGNE carry?

Neurogene Inc. (NGNE) reported $9.89M of total debt, with net debt of -$93.95M.